The Inevitable Outcome: Diabetes Safety Model Expands to Weight Loss…and Beyond?
This article was originally published in RPM Report
Executive Summary
The cardiovascular outcomes standard used for diabetes drugs since 2008 is moving to weight loss. That is important in itself, but also for what it says about the lessons FDA has taken from the diabetes experience—and what it might mean about regulatory expectations for other chronic drug classes in the future.